GGHC
WX

Gilder Gagnon Howe & Co’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-256,101
Closed -$11.1M – 286
2015
Q3 		$11.1M Buy
256,101
+51,963
+25% +$2.19M 0.18% 92
2015
Q2 		$8.63M Buy
+204,138
New +$8.61M 0.11% 125

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Gilder Gagnon Howe & Co's WX Position: Q4 2015 in Review

Gilder Gagnon Howe & Co sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 256,101 shares — an estimated $11.1M sold.

Gilder Gagnon Howe & Co first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $11.1M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Gilder Gagnon Howe & Co reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 256,101 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $11.1M.
  • Gilder Gagnon Howe & Co first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
  • Gilder Gagnon Howe & Co's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $11.1M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2015, filed 4 Feb 2016.